Skip to main content
Caplight Logo









Medvolt

Medvolt

Private
PuneHealthcare & Life Scienceshttps://medvolt.ai

Last Round

Seed

Nov 6, 2025

Total Funding Raised

$250,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Medvolt operates in Healthcare & Life Sciences and is based in Pune. Its latest recorded funding round was a Pre Seed round in November 2025.

Medvolt is a health tech company that provides an AI-driven platform using generative models and molecular simulations to accelerate preclinical drug discovery for the life sciences and healthcare industries.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics, Platform-as-a-Service

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Data as a Service, Revenue Share

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Medvolt Comparables

Compare Medvolt with similar companies based on industry and business-model similarity.

Medvolt comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Iktos
82%
Standigm
81%
Insilico Medicine
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Medvolt Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 6, 2025
Pre SeedNov 6, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Medvolt Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 32% MoM.

  • May 12, 2026

    Monthly visitors increased 222% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Medvolt Filings

Explore SEC and related filing metadata, where available.

Medvolt filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Medvolt's valuation, stock price, and market status.

Is Medvolt a public or private company?

Medvolt is a private company.

What is the current stock price of Medvolt?

Medvolt is a private company, so its shares have no public market price. Caplight tracks Medvolt's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Medvolt worth (valuation)?

Valuation information for Medvolt is not publicly available.

Can I buy Medvolt stock?

Medvolt shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Medvolt's last funding round?

Medvolt's most recent funding round was Seed on November 6, 2025.

Who are the main investors in Medvolt?

Key investors in Medvolt include Lead Invest.

Will Medvolt IPO soon?

No public IPO plans have been announced for Medvolt.

How can I track Medvolt secondary market activity?

Caplight tracks bids, offers, and trades in Medvolt's shares on secondary markets.

Firmographic Details

HeadquartersPune
Employee Range7
Year Founded2020
Last FundingNov 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?